Observationally, circulating IGF-I levels are associated with increased breast cancer risk in both pre-and postmenopausal women (13) and recent MR estimates further support causality between circulating IGF-I and breast cancer risk (15). This evidence concerns the gene IGF1 and breast carcinoma.